Guardant Health (GH) Income from Non-Controlling Interests (2018 - 2021)
Guardant Health's (GH) quarterly Income from Non-Controlling Interests came in at $18.6 million in Q4 2021, up 2557.14% year-on-year from $700000.0 in Q4 2020, and up 708.7% quarter-over-quarter from $2.3 million in Q1 2021.
Guardant Health (GH) Income from Non-Controlling Interests (2018 - 2021) Analysis & Trends
Guardant Health has disclosed Income from Non-Controlling Interests across 4 years of filings, most recently posting $18.6 million for Q4 2021.
- Income from Non-Controlling Interests for Q4 2021 came in at $18.6 million, up 2557.14% year-over-year; the trailing twelve-month figure through Sep 2022 was $18.6 million (up 520.0% YoY), and the FY2021 annual result was $20.9 million, up 178.67% from the prior year.
- Income from Non-Controlling Interests came in at $18.6 million for Q4 2021 at Guardant Health, up from $2.3 million in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $18.6 million in Q4 2021 to a low of -$4.1 million in Q1 2020.
- The 4-year median for Income from Non-Controlling Interests is $1.6 million (2018), against an average of $3.1 million.
- Across the five-year window, Income from Non-Controlling Interests slumped 187.23% in 2020 and surged 2557.14% in 2021, its largest moves.
- Guardant Health's Income from Non-Controlling Interests stood at -$150000.0 in 2018, then soared by 2166.67% to $3.1 million in 2019, then plunged by 77.42% to $700000.0 in 2020, then soared by 2557.14% to $18.6 million in 2021.
- The last three Income from Non-Controlling Interests figures came in at $18.6 million (Q4 2021), $2.3 million (Q1 2021), and $700000.0 (Q4 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 5.00 Mn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | - |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | - |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 1.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | - |
| 10 | Guardant Health | 17.09 Bn | 15.99 Bn | 196.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 18.60 Mn |
| Mar 31, 2021 | 2.30 Mn |
| Dec 31, 2020 | 700,000.00 |
| Sep 30, 2020 | 6.00 Mn |
| Jun 30, 2020 | 4.90 Mn |
| Mar 31, 2020 | -4.10 Mn |
| Dec 31, 2019 | 3.10 Mn |
| Sep 30, 2019 | -300,000.00 |
| Jun 30, 2019 | 300,000.00 |
| Mar 31, 2019 | 4.70 Mn |
| Dec 31, 2018 | -150,000.00 |
| Sep 30, 2018 | 950,000.00 |